UBS Group’s BriaCell Therapeutics Corp. Warrant BCTXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24 | Sell |
314
-2,375
| -88% | -$182 | ﹤0.01% | 8783 |
|
|
2025
Q1 | $274 | Sell |
2,689
-3,724
| -58% | -$379 | ﹤0.01% | 8537 |
|
|
2024
Q4 | $1.85K | Sell |
6,413
-22,645
| -78% | -$6.54K | ﹤0.01% | 7908 |
|
|
2024
Q3 | $11.9K | Buy |
29,058
+19,035
| +190% | +$7.81K | ﹤0.01% | 6447 |
|
|
2024
Q2 | $2.7K | Buy |
+10,023
| New | +$2.7K | ﹤0.01% | 7150 |
|
|
2023
Q4 | – | Sell |
-142
| Closed | -$351 | – | 8076 |
|
|
2023
Q3 | $351 | Buy |
+142
| New | +$351 | ﹤0.01% | 7412 |
|
|
2023
Q1 | – | Sell |
-1,441
| Closed | -$2.97K | – | 8476 |
|
|
2022
Q4 | $2.97K | Sell |
1,441
-1,492
| -51% | -$3.07K | ﹤0.01% | 8395 |
|
|
2022
Q3 | $8K | Sell |
2,933
-2,140
| -42% | -$5.84K | ﹤0.01% | 7586 |
|
|
2022
Q2 | $13K | Buy |
5,073
+3,936
| +346% | +$10.1K | ﹤0.01% | 6453 |
|
|
2022
Q1 | $6K | Buy |
+1,137
| New | +$6K | ﹤0.01% | 7892 |
|
|
2021
Q4 | – | Sell |
-2,082
| Closed | -$10K | – | 9101 |
|
|
2021
Q3 | $10K | Buy |
+2,082
| New | +$10K | ﹤0.01% | 6839 |
|